Prophylactic role of homeopathic medicine Belladonna 200 in brain fever

Efficacy of Homoeopathic Medicine Belladonna 200 in preventing Acute Encephalitis Syndrome in children residing in an endemic region - A cluster randomized, double blind, double arm, placebo controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014296

Enrollment

50000

Registered

2018-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Belladonna 200: 16 doses Control Intervention1: Placebo: 16 doses

Eligibility

Inclusion criteria

Inclusion criteria: 1 Apparently healthy children of either sex, living in the same community, Acute Encephalitis Syndrome is endemic. 2 Informed consent from the head of the family for all the children in that family.

Exclusion criteria

Exclusion criteria: 1 Symptoms of current Acute Encephalitis Syndrome 2 Suffering from known immune compromised diseases

Design outcomes

Primary

Measure	Time frame
The primary end point will be suffering from AES after giving Belladonna or placebo during the 4 monthsâ?? period of the study.Timepoint: 4 months	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Praveen Oberai

Central Council for Research in Homoeopathy

varanasiroja@gmail.com

Outcome results